Immunocore Expands IO Pact With Genentech To Target MAGE-A Antigens

 
• By Sten Stovall
Melanoma
MAGE-A antigens Are attractive targets for active specific and adoptive cancer immuno-therapies • Source: Shutterstock

More from Deals

More from Business